Results 181 to 190 of about 63,206 (209)

Tenofovir

Reactions Weekly, 2013
  +4 more sources

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Peter L Anderson, Robert M Grant   +2 more
exaly  

Tenofovir

Reactions Weekly, 2015
openaire   +1 more source

Tenofovir

Reactions Weekly, 2003
openaire   +2 more sources

Tenofovir

Reactions Weekly, 2019
openaire   +2 more sources

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Paul E Sax, Michael T Yin, Fa Post
exaly  

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2013
Michael Martin, Manoj Leethochawalit, Craig W Hendrix   +2 more
exaly  

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Lancet, The, 2017
Paul E Sax, Anton L Pozniak, Andrea Antinori   +2 more
exaly  

Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults

Lancet, The, 2004
Esteban Martinez, Felipe Garcia, Jose M Gatell   +2 more
exaly  

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Science, 2010
Anneke C Grobler, Cheryl Baxter, Leila E Mansoor   +2 more
exaly